Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 19, 2018 08:05 ET | Source: Organovo, Inc.

Organovo Announces Release Date for Fiscal First-Quarter 2019 Financial Results

SAN DIEGO, July 19, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, August 9, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the...
May 31, 2018 16:05 ET | Source: Organovo, Inc.

Organovo Reports Fiscal Fourth-Quarter and Full-Year 2018 Results; Company Announces Key Goals for Fiscal-Year 2019

- Lead Investigational New Drug (“IND”) program for Alpha-1-antitrypsin deficiency (“A1AT”) received FDA’s orphan drug designation and is on track for commencing IND-enabling studies in fiscal 2019 -...
May 14, 2018 08:05 ET | Source: Organovo, Inc.

Organovo Announces Release Date for Fiscal Fourth-Quarter 2018 Financial Results

SAN DIEGO, May 14, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, May 31, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the...
May 10, 2018 08:05 ET | Source: Organovo, Inc.

Organovo to Present New Preclinical Data for Its Liver Therapeutic Tissue IND-Track Programs at the World Advanced Therapies and Regenerative Medicine Congress

SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it will present new preclinical data showing the strong functionality of its liver...
May 03, 2018 08:05 ET | Source: Organovo, Inc.

Organovo and Samsara Sciences Partner with New Manufacturing USA Institute

SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced it has joined a new public-private Manufacturing USA initiative, the Advanced...
April 24, 2018 08:05 ET | Source: Organovo, Inc.

Organovo to Present at 2nd Annual NASH Summit

SAN DIEGO, April 24, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it will present at the 2nd Annual NASH Summit in Boston, Ma. on Tuesday, April...
April 16, 2018 08:05 ET | Source: Organovo, Inc.

Organovo Achieves Key Development Milestones for Its Liver Disease and Intestinal Tissue Models

SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that along with its collaborators, it has achieved several breakthrough capabilities...
April 12, 2018 08:05 ET | Source: Organovo, Inc.

Organovo Presents Data on Modeling Liver Disease Using 3D Bioprinted Human Liver Tissue at The International Liver Congress™

SAN DIEGO, April 12, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today presented data on modeling non-alcoholic fatty liver disease (“NAFLD”) using its 3D bioprinted...
March 26, 2018 08:05 ET | Source: Organovo, Inc.

Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement With Lonza Bioscience Solutions

SAN DIEGO, March 26, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that its wholly-owned subsidiary, Samsara Sciences, Inc. (“Samsara”), a provider of...
March 15, 2018 08:05 ET | Source: Organovo, Inc.

Organovo to Present at H.C. Wainwright Nash Investor Conference

SAN DIEGO, March 15, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that Chief Executive Officer Taylor J. Crouch is scheduled to speak at the H.C....